BD (NYSE:BDX) today posted first-quarter financial results that topped the consensus forecast and included increased full-year guidance. Shares of BDX were up slightly to $255.46 apiece in morning trading. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up more than 14%. The Franklin Lakes, New Jersey–based […]
How Embecta started strong and what’s ahead for the BD diabetes spinoff
Ten months after spinning off from BD, Embecta CEO Dev Kurdikar lays out what the future holds for the diabetes technology company. When Embecta became a standalone company in April 2022, CFO Jake Elguicze said he felt it was “uniquely positioned.” As a pure-play diabetes technology developer, its beginning phase hardly mirrors a normal startup. The former diabetes […]
Phillips-Medisize unveils new disposable injector pen
Phillips-Medisize, a Molex company, announced today that it expanded its product portfolio with a new disposable pen injector. Hudson, Wisconsin-based Phillips-Medisize designed the new injector for high-volume manufacturing. It intends to offer pharmaceutical companies a familiar, competitive pen injector for faster, more efficient and cost-effective market entry. The company plans to display the pen at […]
Ronovo Surgical unveils Carina surgical robot platform
Ronovo Surgical announced today that it closed a new round of financing, bringing its total funds raised to more than $50 million since 2020. Shanghai-based Ronovo develops broad, cross-specialty robotic-assisted surgery (RAS) technology. LongRiver Investments led the latest financing round. Existing investors Lilly Asia Ventures, Vivo Capital, Matrix Partners China and GGV Capital participated. CEC […]
Baxter, Miromatrix partner on liver failure research
Baxter (NYSE:BAX) and Miromatrix Medical (Nasdaq:MIRO) today announced a collaborative research agreement on acute liver failure (ALF) treatments. As part of the collaboration, Eden Prairie, Minnesota-based Miromatrix created a new liver therapy. The therapy, called MiroLiverELAP, combines a Miromatrix single-use bioengineered liver with Baxter’s PrisMax system. Miromatrix designed the MiroLiverELAP to provide external support to […]
Invacare begins financial restructuring as two subsidiaries file Chapter 11
Invacare (NYSE:IVC) announced today that it initiated a number of actions in an effort to position itself for long-term success. The Elyria, Ohio–based maker of wheelchairs, medical beds, wound care products and more entered into a “Restructuring Support Agreement” (RSA). The RSA covers substantially all of its debt holders. That includes its term loan lender, […]
Edwards stock up on Street-beating Q4
Edwards Lifesciences (NYSE:EW) stock is up today — a day after the company announced fourth-quarter results that beat the consensus forecast. Shares of EW were up more than 3% at $79.63 apiece by late morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the day […]
Boston Scientific posts Q4 EPS miss despite massive bottom-line gain
Boston Scientific (NYSE:BSX) shares rose before the market opened today on fourth-quarter results that came in mixed compared to the consensus forecast. Shares of BSX were up more than 1% at $46.97 apiece by midday trading today. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose more […]
Fractyl Health ‘encouraged’ by results from diabetes reversal study
Fractyl Health announced today that six-month data from a study of its diabetes reversal tech demonstrated improvements in glucose control. Interim data came from the human clinical experience in Fractyl’s Revita-T2Di long-term, open-label cohort. Revita, a procedure that remodels the duodenal lining via hydrothermal ablation, has FDA breakthrough device designation. The FDA approved an investigational […]
AtriCure treats first patient in stroke prevention trial
AtriCure (Nasdaq:ATRC) announced today that it treated the first patient in its left atrial appendage exclusion for stroke prevention (LeAAPS) trial. U.S. co-principal investigator Dr. Marc Gerdisch treated the first patient at Franciscan St. Francis Heart Center in Indianapolis. The prospective, randomized, blinded investigational device exemption (IDE) trial will evaluate the safety and effectiveness of […]
FDA approves fourth-gen rechargeable sacral neuromod tech from Axonics
Axonics (Nasdaq:AXNX) announced today that the FDA approved its fourth-generation R20 rechargeable sacral neuromodulation system. The implantable system provides therapy for patients suffering from overactive bladder or fecal incontinence. The approval indicates the Axonics R20 for a functional life in the body of at least 20 years. It also reduces the frequency with which a […]